DE3687899T2 - Verfahren und zusammensetzung zur regelung des serumkalziumspiegels von saeugetieren. - Google Patents

Verfahren und zusammensetzung zur regelung des serumkalziumspiegels von saeugetieren.

Info

Publication number
DE3687899T2
DE3687899T2 DE8686904723T DE3687899T DE3687899T2 DE 3687899 T2 DE3687899 T2 DE 3687899T2 DE 8686904723 T DE8686904723 T DE 8686904723T DE 3687899 T DE3687899 T DE 3687899T DE 3687899 T2 DE3687899 T2 DE 3687899T2
Authority
DE
Germany
Prior art keywords
mammals
composition
serum calcium
regulating
liposome
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE8686904723T
Other languages
English (en)
Other versions
DE3687899D1 (de
Inventor
Y Hostetler
J Deftos
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of California
University of California Berkeley
Original Assignee
University of California
University of California Berkeley
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of California, University of California Berkeley filed Critical University of California
Publication of DE3687899D1 publication Critical patent/DE3687899D1/de
Application granted granted Critical
Publication of DE3687899T2 publication Critical patent/DE3687899T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22Hormones
    • A61K38/23Calcitonins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22Hormones
    • A61K38/29Parathyroid hormone (parathormone); Parathyroid hormone-related peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/127Liposomes
DE8686904723T 1985-08-01 1986-07-25 Verfahren und zusammensetzung zur regelung des serumkalziumspiegels von saeugetieren. Expired - Fee Related DE3687899T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/761,751 US4692433A (en) 1983-10-12 1985-08-01 Method and composition for regulating serum calcium levels of mammals
PCT/US1986/001553 WO1987000750A1 (en) 1985-08-01 1986-07-25 A method and composition for regulating serum calcium levels of mammals

Publications (2)

Publication Number Publication Date
DE3687899D1 DE3687899D1 (de) 1993-04-08
DE3687899T2 true DE3687899T2 (de) 1993-06-24

Family

ID=25063174

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8686904723T Expired - Fee Related DE3687899T2 (de) 1985-08-01 1986-07-25 Verfahren und zusammensetzung zur regelung des serumkalziumspiegels von saeugetieren.

Country Status (9)

Country Link
US (1) US4692433A (de)
EP (1) EP0233901B1 (de)
JP (1) JPS63500378A (de)
AT (1) ATE86102T1 (de)
AU (1) AU6148186A (de)
CA (1) CA1277595C (de)
DE (1) DE3687899T2 (de)
IL (1) IL79547A0 (de)
WO (1) WO1987000750A1 (de)

Families Citing this family (80)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5223263A (en) * 1988-07-07 1993-06-29 Vical, Inc. Liponucleotide-containing liposomes
US6448392B1 (en) 1985-03-06 2002-09-10 Chimerix, Inc. Lipid derivatives of antiviral nucleosides: liposomal incorporation and method of use
US4917951A (en) * 1987-07-28 1990-04-17 Micro-Pak, Inc. Lipid vesicles formed of surfactants and steroids
US5023086A (en) * 1987-03-13 1991-06-11 Micro-Pak, Inc. Encapsulated ionophore growth factors
US5628936A (en) * 1987-03-13 1997-05-13 Micro-Pak, Inc. Hybrid paucilamellar lipid vesicles
US4911928A (en) * 1987-03-13 1990-03-27 Micro-Pak, Inc. Paucilamellar lipid vesicles
US5234767A (en) * 1987-03-13 1993-08-10 Micro-Pak, Inc. Hybrid paucilamellar lipid vesicles
US5000960A (en) * 1987-03-13 1991-03-19 Micro-Pak, Inc. Protein coupling to lipid vesicles
US4942038A (en) * 1987-03-13 1990-07-17 Micro Vesicular Systems, Inc. Encapsulated humectant
US4855090A (en) * 1987-03-13 1989-08-08 Micro-Pak, Inc. Method of producing high aqueous volume multilamellar vesicles
US5938654A (en) * 1987-06-25 1999-08-17 Alza Corporation Osmotic device for delayed delivery of agent
US4853228A (en) * 1987-07-28 1989-08-01 Micro-Pak, Inc. Method of manufacturing unilamellar lipid vesicles
US5019174A (en) * 1988-03-03 1991-05-28 Micro Vesicular Systems, Inc. Removing oil from surfaces with liposomal cleaner
US5019392A (en) * 1988-03-03 1991-05-28 Micro-Pak, Inc. Encapsulation of parasiticides
US5104736A (en) * 1988-03-03 1992-04-14 Micro-Pak, Inc. Reinforced paucilamellar lipid vesicles
US5160669A (en) * 1988-03-03 1992-11-03 Micro Vesicular Systems, Inc. Method of making oil filled paucilamellar lipid vesicles
US6252060B1 (en) 1988-07-07 2001-06-26 Nexstar Pharmaceuticals, Inc. Antiviral liponucleosides: treatment of hepatitis B
US6599887B2 (en) 1988-07-07 2003-07-29 Chimerix, Inc. Methods of treating viral infections using antiviral liponucleotides
US5817638A (en) * 1988-07-07 1998-10-06 Nexstar Pharmaceuticals, Inc. Antiviral liponucleosides: treatment of hepatitis B
EP0429442B1 (de) * 1988-08-22 1993-12-29 DDS Technology, Limited Zahnbehandlung durch freisetzung von vesikeln
US4942036A (en) * 1988-08-25 1990-07-17 Blair Geho W Therapy by vesicle delivery to the hydroxyapatite of bone
US5026825A (en) * 1988-09-08 1991-06-25 Rhone-Poulenc Rorer Pharmaceuticals Inc. Intranasal calcitonin formulations
JPH0395118A (ja) * 1989-09-07 1991-04-19 Green Cross Corp:The プロスタグランジン含有脂肪小体製剤
WO1991004019A1 (en) * 1989-09-12 1991-04-04 The Regents Of The University Of California Therapeutic peptides and proteins
US5116828A (en) * 1989-10-26 1992-05-26 Nippon Zoki Pharmaceutical Co., Ltd. Pharmaceutical composition for treatment of osteoporosis
US5578323A (en) 1992-06-15 1996-11-26 Emisphere Technologies, Inc. Proteinoid carriers and methods for preparation and use thereof
US5714167A (en) 1992-06-15 1998-02-03 Emisphere Technologies, Inc. Active agent transport systems
US5693338A (en) * 1994-09-29 1997-12-02 Emisphere Technologies, Inc. Diketopiperazine-based delivery systems
US6344213B1 (en) 1996-03-29 2002-02-05 Emisphere Technologies, Inc. Compounds and compositions for delivering active agents
US6099856A (en) * 1992-06-15 2000-08-08 Emisphere Technologies, Inc. Active agent transport systems
US6221367B1 (en) 1992-06-15 2001-04-24 Emisphere Technologies, Inc. Active agent transport systems
US5443459A (en) * 1991-01-30 1995-08-22 Alza Corporation Osmotic device for delayed delivery of agent
US5688761A (en) * 1991-04-19 1997-11-18 Lds Technologies, Inc. Convertible microemulsion formulations
CA2108266C (en) * 1991-04-19 2003-06-03 Albert J. Owen Convertible microemulsion formulations
US5683714A (en) * 1991-04-19 1997-11-04 Nexstar Pharmaceuticals, Inc. Liposomal cyclosporin pharmaceutical formulation
US6916489B2 (en) * 1992-06-15 2005-07-12 Emisphere Technologies, Inc. Active agent transport systems
US5869305A (en) * 1992-12-04 1999-02-09 The University Of Pittsburgh Recombinant viral vector system
US6461643B2 (en) 1993-04-22 2002-10-08 Emisphere Technologies, Inc. Oral drug delivery compositions and methods
US20010003001A1 (en) 1993-04-22 2001-06-07 Emisphere Technologies, Inc. Compounds and compositions for delivering active agents
US5459126A (en) * 1993-05-21 1995-10-17 California Institute Of Technology Method for decreasing calcium uptake by cells using selected polycations
CN1151836C (zh) * 1995-03-31 2004-06-02 艾米斯菲尔技术有限公司 用作传送活性剂的化合物和组合物
US5866536A (en) * 1995-03-31 1999-02-02 Emisphere Technologies, Inc. Compounds and compositions for delivering active agents
US6001347A (en) * 1995-03-31 1999-12-14 Emisphere Technologies, Inc. Compounds and compositions for delivering active agents
US6090958A (en) * 1995-03-31 2000-07-18 Emisphere Technologies, Inc. Compounds and compositions for delivering active agents
US5989539A (en) * 1995-03-31 1999-11-23 Emisphere Technologies, Inc. Compounds and compositions for delivering active agents
DE19517430A1 (de) * 1995-05-12 1996-11-14 Boehringer Mannheim Gmbh Pharmazeutische Darreichungsform von Parathormon mit einer zwei- bis sechsstündigen Wirkstoff-Freisetzungsperiode
US5693336A (en) * 1995-06-07 1997-12-02 Nexstar Pharmaceuticals, Inc. Blood stable liposomal cyclosporin formulations
US5750147A (en) 1995-06-07 1998-05-12 Emisphere Technologies, Inc. Method of solubilizing and encapsulating itraconazole
WO1997010197A1 (en) * 1995-09-11 1997-03-20 Emisphere Technologies, Inc. METHOD FOR PREPARING φ-AMINOALKANOIC ACID DERIVATIVES FROM CYCLOALKANONES
AU1558197A (en) * 1996-02-01 1997-08-22 Chugai Seiyaku Kabushiki Kaisha Preventives and remedies for thrombocytopenia
WO1997047288A1 (en) 1996-06-14 1997-12-18 Emisphere Technologies, Inc. Microencapsulated fragrances and method for preparation
CA2243643A1 (en) 1996-11-18 1998-05-28 Susan Haas Methods and compositions for inducing oral tolerance in mammals
US5804688A (en) * 1997-02-07 1998-09-08 Emisphere Technologies, Inc. Compounds and compositions for delivering active agents
US5773647A (en) * 1997-02-07 1998-06-30 Emisphere Technologies, Inc. Compounds and compositions for delivering active agents
US6313088B1 (en) 1997-02-07 2001-11-06 Emisphere Technologies, Inc. 8-[(2-hydroxy-4-methoxy benzoyl) amino]-octanoic acid compositions for delivering active agents
US6060513A (en) * 1997-02-07 2000-05-09 Emisphere Technologies, Inc. Compounds and compositions for delivering active agents
US5990166A (en) * 1997-02-07 1999-11-23 Emisphere Technologies, Inc. Compounds and compositions for delivering active agents
US6358504B1 (en) 1997-02-07 2002-03-19 Emisphere Technologies, Inc. Compounds and compositions for delivering active agents
US5863944A (en) * 1997-04-30 1999-01-26 Emisphere Technologies, Inc. Compounds and compositions for delivering active agents
US5962710A (en) * 1997-05-09 1999-10-05 Emisphere Technologies, Inc. Method of preparing salicyloylamino acids
EP1100771B1 (de) 1998-07-27 2005-05-11 Emisphere Technologies, Inc. Stoffe und zusammensetzungen für die verabreichung aktiver substanzen
WO2000006150A1 (en) * 1998-07-28 2000-02-10 Synergen Ag Use of creatine compounds for treatment of bone or cartilage cells and tissues
NZ512581A (en) 1999-01-08 2002-12-20 Univ Virginia Commonwealth Polymeric delivery agents comprising a polymer conjugated to a modified amino acid and derivatives thereof
MXPA01008611A (es) 1999-02-26 2003-06-24 Emisphere Tech Inc Compuestos y composiciones para suministrar agentes activos.
EP1175390B1 (de) * 1999-04-05 2005-02-02 Emisphere Technologies, Inc. Dinatrium-salze, monohydrate und ethanol-solvate
US7279597B1 (en) 1999-11-05 2007-10-09 Emisphere Technologies, Inc. Phenyl amine carboxylic acid compounds and compositions for delivering active agents
US7129274B1 (en) 1999-11-05 2006-10-31 Emisphere Technologies Inc. Phenoxy carboxylic acid compounds and compositions for delivering active agents
EP1237872B1 (de) 1999-12-16 2008-02-27 Emisphere Technologies, Inc. Verbindungen und zusammensetzungen zur abgabe aktiver wirkstoffe
CA2413860A1 (en) * 2000-06-22 2001-12-27 Michael F. Holick Regulation of cellproliferation and differentiation using topically applied peptides
US20040022838A1 (en) * 2001-06-20 2004-02-05 Holick Michael F. Regulation of cell proliferation and differentiation using topically applied peptides
US20040013719A1 (en) * 2000-10-06 2004-01-22 Holick Michael F. Regulation of cell proliferation and differentiation using topically applied nucleric acid molecules
US20030225300A1 (en) * 2001-04-19 2003-12-04 Emisphere Technologies Inc. Compounds and compositions for delivering active agents
MXPA03011027A (es) * 2001-06-01 2004-03-19 Novartis Ag Administracion oral de hormona paratiroides y calcitonina.
RU2322256C2 (ru) * 2001-08-17 2008-04-20 Новартис Аг 5-cnac в качестве агента для пероральной доставки фрагментов паратироидного гормона
US20050054557A1 (en) * 2002-05-09 2005-03-10 Goldberg Michael M. Compositions for delivering parathyroid hormone and calcitonin
CA2546111A1 (en) * 2003-11-25 2005-06-16 Novartis Ag Biomarkers for the efficacy of calcitonin and parathyroid hormone treatment
JP2005209106A (ja) * 2004-01-26 2005-08-04 Nec Corp 携帯通信端末、受信メール管理方法、プログラムおよび記録媒体
FR2925333B1 (fr) 2007-12-19 2012-04-13 Farid Bennis Compositions pharmaceutiques renfermant au moins un principe actif proteinique protege des enzymes digestives
JP5892940B2 (ja) 2009-11-25 2016-03-23 アリスジェン ソシエテ アノニム クラウン化合物及び/又は対イオンと複合体化されたペプチドを含む粘膜送達組成物
WO2012130193A1 (en) 2011-03-31 2012-10-04 Zentiva, K.S. Non-covalent soluble complexes of teriparatide with polysaccharides and a dosage form of teriparatide for oral administration

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4151276A (en) * 1975-05-12 1979-04-24 Armour Pharmaceutical Company Method of suppressing gastric acid secretion by the oral administration of calcitonin
US4241051A (en) * 1977-11-04 1980-12-23 Christie Robert B Calcitonin
JPS55153713A (en) * 1979-05-02 1980-11-29 Kureha Chem Ind Co Ltd Pharmaceutical preparation of ribosome containing active substance
US4342826A (en) * 1980-02-04 1982-08-03 Collaborative Research, Inc. Immunoassay products and methods
US4459295A (en) * 1980-03-07 1984-07-10 Interx Research Corporation Method of increasing oral absorption of glycosidic and related antibiotics

Also Published As

Publication number Publication date
JPS63500378A (ja) 1988-02-12
EP0233901B1 (de) 1993-03-03
ATE86102T1 (de) 1993-03-15
CA1277595C (en) 1990-12-11
EP0233901A4 (de) 1988-09-07
DE3687899D1 (de) 1993-04-08
EP0233901A1 (de) 1987-09-02
AU6148186A (en) 1987-03-05
WO1987000750A1 (en) 1987-02-12
US4692433A (en) 1987-09-08
IL79547A0 (en) 1986-10-31

Similar Documents

Publication Publication Date Title
DE3687899D1 (de) Verfahren und zusammensetzung zur regelung des serumkalziumspiegels von saeugetieren.
DE3365465D1 (en) Oral galenical forms of mopidamol
DE3572122D1 (en) Composition and method for enhancing absorption of drugs from gastrointestinal tract using acylcarnitines
EP0591914A3 (en) Retrovirus of the hiv-group and its application
DE3889536D1 (de) Behandlung von krebs mit somatostatin und mit analogen davon.
ES2058815T3 (es) Composiciones farmaceuticas para el tratamiento de desarreglos gastrointestinales.
DK384084A (da) Vaeksthormonfrigoerende peptider samt fremgangsmaade til behandling af pattedyr hermed
DE69828706D1 (de) Behälter zur getrennten aufnahme von fliessfähigen massen sowie mischung dieser massen nach bedarf
OA07800A (fr) Faction polypeptidiques inductrices d'anticorps protecteurs contre des parasites du paludisme et compositions immunogènes les contenant.
DE3780770D1 (de) Therapeutisches gemisch aus einem faenger von freien radikalen oder einem stoffwechsel-hemmer und einem biologisch aktiven protein.
IT8522027A0 (it) Composizioni farmaceutiche comprendenti acht (1-24) per il trattamento terapeutico degli stati di shock e dell'insufficienza respiratoria e cardiocircolatoria.
IT8149979A0 (it) Procedimento per la produzione dell'ormone paratiroideo umano
BE896943A (fr) Analogues d'hormones neurohypophysaires exercant des effets inhibiteurs
ES8506597A1 (es) Un procedimiento para preparar un peptido de resina.
DE413627T1 (de) Teilchen von gelatine und aminosaeure welche mit harzen gemischt werden.
Chapuy et al. Parathyroid function during treatment with salmon calcitonin
DE3485883D1 (de) Rekombinante materialien und verfahren zur herstellung von menschliche konnektive gewebe aktivierende peptide iii und deren analoge.
ZA832509B (en) N-carboxymethyl(unsaturated)ysyl and alpha-(epsilon-amino-alkyl)glycyl amino acid antihypertensive agents
ATA338382A (de) Verfahren zur aufbereitung und anreicherung von eisenarmen eisenerzen

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee